Amanda Mull

Person

Mentions

Episodes

Claims

Amanda Mull, mentioned 19 times across podcast episodes and expert conversations analyzed by Sonic.

What Amanda Mull has said

Robert F. Kennedy Jr. has instructed the FDA's regulatory committee on compounded pharmaceuticals to investigate allowing certain peptides to be produced by compounding pharmacies.

neutral·Amanda Mull

A testing lab outside of Prague owned by chemist Peter Magic has become a central hub for the global black market peptide trade by offering purity and sterility testing services.

neutral·Amanda Mull

It is unlikely that black market peptides will gain formal FDA approval for commercial sale because no single company is incentivized to fund the expensive clinical trials required, as the drugs lack patent protection.

neutral·Amanda Mull

Robert F. Kennedy Jr. has instructed the FDA's regulatory committee on compounded pharmaceuticals to investigate allowing certain peptides to be produced by compounding pharmacies.

Expert perspectiveAmanda MullJun 27

A testing lab outside of Prague owned by chemist Peter Magic has become a central hub for the global black market peptide trade by offering purity and sterility testing services.

Expert perspectiveAmanda MullJun 27

Black market peptides are typically imported as a powder in glass vials from Chinese manufacturers, who also produce active pharmaceutical ingredients for legal drugs.

Expert perspectiveAmanda MullJun 27

Some Chinese manufacturers that produce black market peptides also produce active pharmaceutical ingredients for legal and safe drugs.

Expert perspectiveAmanda MoleJun 24

Robert F. Kennedy Jr. has publicly stated that he is a fan of peptides.

Expert perspectiveAmanda MoleJun 24

Robert F. Kennedy Jr. has directed the FDA's regulatory committee on compounded pharmaceuticals to consider allowing certain unapproved peptides to be legally produced by compounding pharmacies.

Expert perspectiveAmanda MoleJun 24

Black market peptides are typically imported into the United States as a powder in glass vials from manufacturers in China.

Expert perspectiveAmanda MoleJun 24

The lack of patent protection for many peptides disincentivizes any single company from funding the expensive FDA approval process, as competitors could also market the drug upon approval.

Expert perspectiveAmanda MoleJun 24

Unapproved peptides are illegal to sell and prescribe in the United States, classifying them as black market substances.

Expert perspectiveAmanda MoleJun 24

Chemist Peter Magic owns a testing lab near Prague that serves as a central node in the global black market peptide trade by testing substances for purity and sterility.

Expert perspectiveAmanda MoleJun 24

The current U.S. black market for peptides is estimated to be valued between $1 billion and $2 billion.

Expert perspectiveAmanda MullJun 21

Quince is able to respond to new fashion trends within a few weeks, compared to the traditional 6 to 18-month cycle for other clothing brands.

Expert perspectiveAmanda MullJun 19

Amanda Mull asserts that the COVID-19 pandemic negatively impacted Everlane's sales because its target market of remote workers no longer needed office attire.

Expert perspectiveAmanda MullJun 19

Amanda Mull theorizes that SHEIN acquired Everlane to compete with Quince by applying its logistics system to a brand that targets higher-income, materials-conscious consumers.

Expert perspectiveAmanda MullJun 19

Amanda Mull characterizes SHEIN's business model as being based on logistics optimization to create margin and lower prices, rather than on design or brand identity.

Expert perspectiveAmanda MullJun 19

Quince was valued at $10 billion in a recent venture funding round, nearly double its valuation from the previous year.

Expert perspectiveAmanda MullJun 19

Amanda Mull argues that direct-to-consumer mattress startups struggled after their launch due to the low purchase frequency of mattresses, which consumers buy roughly once every 10 years.

Expert perspectiveAmanda MullJun 19

Amanda Mull attributes Warby Parker's success to undercutting the quasi-monopoly held by EssilorLuxottica in the prescription glasses market.

Expert perspectiveAmanda MullJun 19

Create a free account to see Amanda Mull's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Entity Detail